Hydrocodone Bitartrate And Acetaminophen Tablet
FDA Label NDC 53746-109

49 label sections · Submitted to the FDA by Amneal Pharmaceuticals Of New York Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Amneal Pharmaceuticals Of New York Llc for the product Hydrocodone Bitartrate And Acetaminophen (NDC 53746-109). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: serious and life-threatening risks from use of hydrocodone bitartrate and acetaminophen tablets, description, clinical pharmacology, indications and usage, contraindications, addiction, abuse, and misuse, life-threatening respiratory depression, risks from concomitant use with benzodiazepines or other cns depressants, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.